Cargando…
52500 Characterization of a Series of 1,4-diaryl-pyrazolo-pyridinones as Anti-Leishmanial Agents
ABSTRACT IMPACT: The first-line chemotherapies used to treat leishmaniasis are highly toxic intravenous antimonials yet drug resistance has begun to develop, causing the use of oral treatment options with high price tags; there is a strong need for new, safe, and effective chemotherapeutic agents to...
Autores principales: | Corman, Hannah N., Shoue, Douglas A., Melancon, Bruce J., McDowell, Mary Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827810/ http://dx.doi.org/10.1017/cts.2021.409 |
Ejemplares similares
-
4040 Investigation of a Series of 1,4-diaryl-pyrazolo-pyridinones as Anti-Leishmanial Agents
por: Corman, Hannah Noel, et al.
Publicado: (2020) -
Recent Advances of Pyridinone in Medicinal Chemistry
por: Lin, Shibo, et al.
Publicado: (2022) -
Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties
por: Corman, Hannah N., et al.
Publicado: (2022) -
β-Nitrostyrenes as Potential Anti-leishmanial Agents
por: Shafi, Syed, et al.
Publicado: (2016) -
Synthesis of New Bis(3-hydroxy-4-pyridinone) Ligands as Chelating Agents for Uranyl Complexation
por: Jin, Bo, et al.
Publicado: (2016)